SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing intense downward pressure driven by concerns over mounting legal challenges, including a lawsuit from the NCAA, and broader industry debates surrounding the regulation of prediction markets. Investors are actively debating the stock's future, with many on community forums expressing bearish sentiment and a preference for shorting the shares amid ongoing insider selling and heightened competition.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant momentum driven by promising clinical data from its new siRNA pipeline for rare muscle diseases, alongside renewed optimism following leadership changes at the FDA's CBER division. The community is actively discussing a potential short squeeze, a possible buyout, and the company's transition into a broader RNA platform, fueling a bullish shift in sentiment despite recent regulatory headwinds.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is facing a wave of intense backlash from users following widespread platform outages and persistent trading restrictions, with the community actively debating whether these failures point to systemic infrastructure weaknesses. Amidst these technical frustrations, users are increasingly discussing legal avenues and comparing the platform to competitors like Interactive Brokers and Robinhood, while some investors monitor how these service disruptions impact the firm's overall market standing.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors rotate out of the stock due to concerns regarding AI infrastructure spending, slowing growth in its cloud and software divisions, and the broader volatility of the Magnificent Seven sector. The community is sharply divided, with many traders lamenting the stock's persistent underperformance and technical breakdown, while long-term investors are increasingly viewing these levels as a deep-value buying opportunity.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention from retail traders who view it as a strategic proxy for high-profile private companies like SpaceX and OpenAI ahead of potential IPO activity. The community is actively debating the fund's premium-to-NAV volatility, with many traders framing it as a squeeze candidate due to its small float while weighing it against other SpaceX-exposed alternatives like SATS and VCX.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh the impact of rising CPU demand and price hikes against ongoing market volatility and sector-wide sentiment shifts. The community remains deeply divided, with bulls pointing to the company's long-term potential in data centers and AI, while others express concerns over geopolitical instability and potential downside price gaps.

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Journey Medical Corp is experiencing high community interest following the FDA approval of Emrosi, with investors keenly focused on the upcoming commercialization strategy and potential for profitability in 2025. Discussion is currently centered on insurance coverage expectations, the upcoming commercialization conference call, and the belief that the stock is undervalued given its potential to capture significant market share from existing rosacea treatments.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is seeing a massive surge in volume and price following a new development agreement with Tower Semiconductor, which integrates its polymer-based modulators into a commercially scalable silicon photonics foundry platform. Community sentiment is overwhelmingly bullish, with many traders framing the partnership as a critical de-risking milestone that connects the company directly to the broader AI infrastructure supply chain alongside industry leaders like NVIDIA.

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund ($VCX) is seeing massive retail interest and extreme volatility as traders scramble for exposure to high-profile private tech holdings like SpaceX and OpenAI. While the community is split between aggressive bulls targeting higher valuations during the current lockup period and skeptics warning of a massive premium over net asset value, the stock continues to act as a magnet for momentum-driven buying.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

Mask Network is trending as investors capitalize on its extreme low-float status following a recent reverse split, sparking comparisons to historical micro-cap runners. The community is actively monitoring technical setups and liquidity for potential momentum swings, while enthusiasm remains high regarding its position in the AI and Web3 infrastructure space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Justice Department’s Antitrust Division said on Thursday that it requires broad divestitures to resolve the challenge to UnitedHealth Group Incorporated’s (UNH) planned $3.3 billion acquisition of home health and hospice services provider Amedisys Inc. (AMED).The proposed <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition">settlement</a>, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states, accounting for approximately $528 million in annual revenue. The locations are spread across Tennessee, Alabama, Georgia, South Carolina, Virginia, Pennsylvania, New York, West Virginia, and Mississippi, among others.The settlement would secure the largest divestiture of outpatient healthcare services to resolve a merger challenge by the number of facilities, the department said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/UNH">UNH</a> fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:1366/132;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_31_56_PM_png_875db7d160.webp" alt="UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1366" height="132"><figcaption>UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>Retail sentiment around <a href="https://stocktwits.com/symbol/AMED">Amedisys</a> trended in the ‘bullish’ territory, accompanied by ‘normal’ levels of retail chatter.<figure class="image"><img style="aspect-ratio:1358/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_33_41_PM_png_b432c28787.webp" alt="AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1358" height="126"><figcaption>AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the divestitures may reduce expected synergies.<stembedurl>https://stocktwits.com/Tokki_/message/624147426</stembedurl>Additionally, the department requires Amedisys to pay a $1.1 million civil penalty and train its corporate and field leadership on antitrust compliance for falsely certifying that the company had truthfully, correctly, and completely responded to the United States’ requests for documents.UNH’s Optum unit submitted a proposal to acquire Amedisys in June 2023. UNH had acquired Amedisys’s rival LHC Group earlier that year through a $5.4 billion deal. However, the U.S. Department of Justice and attorneys general from four U.S. states filed a lawsuit in November 2024 to block the acquisition.“Eliminating the competition between UnitedHealth and Amedisys would harm patients who receive home health and hospice services, insurers who contract for home health services, and nurses who provide home health and hospice services,” the department then said.While shares of UNH are down by 52% this year, AMED is up by 11%.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-gets-price-target-hike-from-wells-fargo/chrmBLTRd3a">This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies

The proposed settlement, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states.

Equity

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates

Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?

Here's Why You Should Retain AMED Stock in Your Portfolio for Now

BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?

Are Medical Stocks Lagging  Amedisys (AMED) This Year?

Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

The DOJ Is Investigating UnitedHealth. Is UNH Stock a Buy, Sell, or Hold Now?

UnitedHealth stock tanked on reports of DOJ investigation. But analysts remain uber bullish on the healthcare services giant.

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

AMED
Amedisys Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMED News

AMEDAmedisys Inc.